DNA damage and the balance between survival and death in cancer biology
- PMID: 26678314
- DOI: 10.1038/nrc.2015.2
DNA damage and the balance between survival and death in cancer biology
Abstract
DNA is vulnerable to damage resulting from endogenous metabolites, environmental and dietary carcinogens, some anti-inflammatory drugs, and genotoxic cancer therapeutics. Cells respond to DNA damage by activating complex signalling networks that decide cell fate, promoting not only DNA repair and survival but also cell death. The decision between cell survival and death following DNA damage rests on factors that are involved in DNA damage recognition, and DNA repair and damage tolerance, as well as on factors involved in the activation of apoptosis, necrosis, autophagy and senescence. The pathways that dictate cell fate are entwined and have key roles in cancer initiation and progression. Furthermore, they determine the outcome of cancer therapy with genotoxic drugs. Understanding the molecular basis of these pathways is important not only for gaining insight into carcinogenesis, but also in promoting successful cancer therapy. In this Review, we describe key decision-making nodes in the complex interplay between cell survival and death following DNA damage.
Similar articles
-
Various modes of cell death induced by DNA damage.Oncogene. 2013 Aug 15;32(33):3789-97. doi: 10.1038/onc.2012.556. Epub 2012 Dec 3. Oncogene. 2013. PMID: 23208502 Review.
-
[Mitochondrial mechanisms of apoptosis in response to DNA damage].Mol Biol (Mosk). 2008 Sep-Oct;42(5):765-71. Mol Biol (Mosk). 2008. PMID: 18988526 Review. Russian.
-
DNA damage-dependent cell cycle checkpoints and genomic stability.DNA Cell Biol. 2006 Jul;25(7):406-11. doi: 10.1089/dna.2006.25.406. DNA Cell Biol. 2006. PMID: 16848682 Review.
-
Cell-cycle control in the face of damage--a matter of life or death.Trends Cell Biol. 2009 Mar;19(3):89-98. doi: 10.1016/j.tcb.2008.12.003. Epub 2009 Jan 23. Trends Cell Biol. 2009. PMID: 19168356 Review.
-
Oxidative stress and oxidative damage in chemical carcinogenesis.Toxicol Appl Pharmacol. 2011 Jul 15;254(2):86-99. doi: 10.1016/j.taap.2009.11.028. Epub 2011 Feb 4. Toxicol Appl Pharmacol. 2011. PMID: 21296097 Review.
Cited by
-
Ginsenosides: an immunomodulator for the treatment of colorectal cancer.Front Pharmacol. 2024 Jun 12;15:1408993. doi: 10.3389/fphar.2024.1408993. eCollection 2024. Front Pharmacol. 2024. PMID: 38939839 Free PMC article. Review.
-
Exposure to wildfire-related PM2.5 and site-specific cancer mortality in Brazil from 2010 to 2016: A retrospective study.PLoS Med. 2022 Sep 19;19(9):e1004103. doi: 10.1371/journal.pmed.1004103. eCollection 2022 Sep. PLoS Med. 2022. PMID: 36121854 Free PMC article.
-
Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma.Int J Mol Sci. 2020 Jul 11;21(14):4910. doi: 10.3390/ijms21144910. Int J Mol Sci. 2020. PMID: 32664581 Free PMC article. Review.
-
Adaptive upregulation of DNA repair genes following benzo(a)pyrene diol epoxide protects against cell death at the expense of mutations.Nucleic Acids Res. 2016 Dec 15;44(22):10727-10743. doi: 10.1093/nar/gkw873. Epub 2016 Sep 30. Nucleic Acids Res. 2016. PMID: 27694624 Free PMC article.
-
Mutational Footprint of Platinum Chemotherapy in a Secondary Thyroid Cancer.JCO Precis Oncol. 2022 Aug;6:e2200183. doi: 10.1200/PO.22.00183. JCO Precis Oncol. 2022. PMID: 36075011 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources